Yun Zhang

Title: Innovations by Inventor Yun Zhang

Introduction

Yun Zhang, a noted inventor based in Jiangsu, China, has made significant contributions to the field of biotechnology with a total of five patents to his name. His innovative work primarily focuses on the development of novel therapeutic methods and DNA assembly technologies, contributing to advancements in cancer treatment and genetic engineering.

Latest Patents

One of Yun Zhang's latest patents is titled "Single-domain antibodies against CLL1 and constructs thereof." This invention includes single-domain antibodies that target CLL1, as well as various constructs, such as chimeric receptors, immune effector cell engagers, and immunoconjugates. These engineered immune effector cells, such as T cells, utilize an anti-CLL1 chimeric receptor and can optionally incorporate a second chimeric receptor targeting another antigen or epitope. This patent also outlines pharmaceutical compositions, kits, and methods for treating cancer.

Another noteworthy patent is "DNA assembly method and its application." This invention relates to a plasmid characterized by having single adjacent Type IIP and Type IIS restriction enzyme recognition sites. The plasmid combines the capabilities of Type IIP and Type IIS restriction enzymes, enabling recursive cycling, SCAR-free assembly, and repeat sequence assembly in recombinant strains.

Career Highlights

Throughout his career, Yun Zhang has worked for various renowned companies in the biotechnology sector. Notably, he has been associated with Panasian Microvent Technologies Corporation and Trend Micro Inc., where his expertise has contributed to multiple groundbreaking projects in the field.

Collaborations

Yun Zhang has collaborated with esteemed colleagues such as Ronghua Ding and Bin Wang. These partnerships have fostered a collaborative environment that has enabled further advancements in his innovative research and developments.

Conclusion

Yun Zhang stands out as a pivotal figure in biotechnology, with a strong portfolio of patents that reflect his commitment to innovation and excellence. His work not only addresses current challenges in cancer treatment but also sets the stage for future breakthroughs in genetic engineering, making him a notable inventor in the field.